Aurinia Announces Upcoming Presentations of New Data on LUPKYNIS® at American College of Rheumatology Convergence and American Society of Nephrology Kidney Week 2025

Core Insights - Aurinia Pharmaceuticals is set to present new data on LUPKYNIS® at two major upcoming conferences: ACR Convergence and ASN Kidney Week 2025 [1] Group 1 - The presentations will focus on the latest findings related to LUPKYNIS®, a treatment for lupus nephritis [1] - These events are significant for the company as they provide a platform to showcase advancements in their product pipeline [1] - The participation in these conferences highlights the company's commitment to addressing unmet medical needs in the field of kidney diseases [1]